OSL:B2I - Euronext Oslo - NO0010633951 - Common Stock - Currency: NOK
Taking everything into account, B2I scores 7 out of 10 in our fundamental rating. B2I was compared to 9 industry peers in the Consumer Finance industry. B2I has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. B2I is valued quite cheap, while showing a decent growth score. This is a good combination! B2I also has an excellent dividend rating. This makes B2I very considerable for value and dividend investing!
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 1.81% | ||
ROE | 5.47% | ||
ROIC | 6.13% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 36.64% | ||
PM (TTM) | 9% | ||
GM | 53.43% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 1.73 | ||
Debt/FCF | 2.57 | ||
Altman-Z | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 2.44 | ||
Quick Ratio | 2.44 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 14.49 | ||
Fwd PE | 7.62 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 1.19 | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 10.61% |
OSL:B2I (5/30/2025, 7:00:00 PM)
12.32
-0.22 (-1.75%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 10.61% |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 14.49 | ||
Fwd PE | 7.62 | ||
P/S | 1.31 | ||
P/FCF | 1.19 | ||
P/OCF | 1.18 | ||
P/B | 0.8 | ||
P/tB | 0.93 | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 1.81% | ||
ROE | 5.47% | ||
ROCE | 7.9% | ||
ROIC | 6.13% | ||
ROICexc | 7.09% | ||
ROICexgc | 7.52% | ||
OM | 36.64% | ||
PM (TTM) | 9% | ||
GM | 53.43% | ||
FCFM | 110.56% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 1.73 | ||
Debt/FCF | 2.57 | ||
Debt/EBITDA | N/A | ||
Cap/Depr | N/A | ||
Cap/Sales | 0.98% | ||
Interest Coverage | 1.45 | ||
Cash Conversion | N/A | ||
Profit Quality | 1228.3% | ||
Current Ratio | 2.44 | ||
Quick Ratio | 2.44 | ||
Altman-Z | N/A |